Free tool
Oncology stocks
We cover 148 companies grouped under the Oncology theme. The median market value in the group is $656.58M. Across the group, the median move over the past trading day is −0.45%. 61% of the 143 with a 200-day average trade above it. Price change over the past year runs from −47.5% to +259.0% across the middle 80 percent of the group, with a median of +23.6%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
148 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% | Oct 30, 2026 |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% | Oct 29, 2026 |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% | Oct 27, 2026 |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% | Nov 4, 2026 |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% | Nov 5, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% | Oct 30, 2026 |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% | Nov 3, 2026 |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% | Oct 27, 2026 |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% | Nov 5, 2026 |
| 0J9P.L | Incyte Corporation | $129.02 | +1.10% | +29.30% | +53.49% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% | Nov 5, 2026 |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% | Oct 27, 2026 |
| 0IJO.L | Exelixis, Inc. | $56.81 | +4.53% | +31.50% | +50.53% | Oct 27, 2026 |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% | Oct 19, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% | Oct 29, 2026 |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% | Nov 9, 2026 |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% | Nov 11, 2026 |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% | Nov 5, 2026 |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% | Nov 3, 2026 |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% | Nov 11, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% | Nov 11, 2026 |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% | Nov 5, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% | Nov 9, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% | Nov 5, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% | Nov 11, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% | Nov 2, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% | Nov 5, 2026 |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% | Nov 5, 2026 |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% | Oct 29, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% | Nov 12, 2026 |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% | Nov 5, 2026 |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% | Nov 2, 2026 |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% | Nov 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% | Nov 16, 2026 |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% | Nov 5, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $26.51 | +15.41% | +18.35% | +18.35% | Nov 12, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% | Nov 12, 2026 |
| IMTX | Immatics N.V. | $9.43 | +7.96% | −9.76% | +74.63% | Nov 17, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% | Nov 19, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% | Nov 5, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% | Nov 3, 2026 |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% | Nov 5, 2026 |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% | Nov 13, 2026 |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% | Nov 12, 2026 |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% | Nov 4, 2026 |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% | Nov 12, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% | Nov 9, 2026 |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% | Nov 11, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% | Nov 3, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% | Nov 3, 2026 |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% | Nov 12, 2026 |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% | Nov 12, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.26 | +7.80% | −24.65% | −0.43% | Nov 11, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% | Nov 5, 2026 |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% | Nov 12, 2026 |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% | Nov 12, 2026 |
| 0QAV.L | Nanobiotix S.A. | 35.02 EUR | −1.38% | +82.87% | +351.98% | Sep 29, 2026 |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% | Nov 3, 2026 |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% | Nov 4, 2026 |
| 0KCS.L | OPKO Health, Inc. | $1.49 | +0.68% | +14.66% | +5.64% | Oct 28, 2026 |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% | Nov 3, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% | Nov 5, 2026 |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% | Nov 9, 2026 |
| 0IL8.L | Kyntra Bio, Inc. | $7.96 | +1.58% | −11.17% | −28.07% | Nov 9, 2026 |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% | Nov 12, 2026 |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% | Nov 5, 2026 |
| 0LOV.L | Verastem, Inc. | $7.15 | +3.62% | −1.79% | −19.93% | Nov 3, 2026 |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% | Nov 5, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% | Nov 12, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% | Nov 12, 2026 |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% | Aug 27, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% | Nov 5, 2026 |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% | Nov 5, 2026 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% | Nov 10, 2026 |
| CATX | Perspective Therapeutics, Inc. | $3.16 | +10.10% | +13.26% | −12.47% | Nov 9, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $46.18 | −1.66% | +104.45% | +136.88% | Nov 5, 2026 |
| IMRX | Immuneering Corporation | $5.15 | +21.46% | −22.21% | −0.77% | Nov 11, 2026 |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% | Oct 29, 2026 |
| PYXS | Pyxis Oncology, Inc. | $3.34 | +14.78% | +190.43% | +145.59% | Nov 2, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $4.84 | +31.52% | +98.36% | +167.40% | Nov 5, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $1.98 | −0.50% | +72.17% | +65.00% | Nov 6, 2026 |
| CGEN | Compugen Ltd. | $2.84 | +25.66% | +83.23% | +93.20% | Nov 9, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $18.23 | +35.54% | −6.37% | +56.21% | Nov 12, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $4.04 | +4.94% | +150.93% | +134.88% | Nov 12, 2026 |
| 0IV3.L | Geron Corporation | $1.53 | −0.97% | +15.53% | +7.77% | Nov 4, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| TARA | Protara Therapeutics, Inc. | $3.91 | −0.76% | −27.32% | +21.05% | Nov 10, 2026 |
| CHRS | Coherus Oncology, Inc. | $1.45 | +0.69% | +5.84% | +27.19% | Nov 5, 2026 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% | Nov 16, 2026 |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% | Aug 27, 2026 |
| 0IMT.L | Photocure ASA | 53.80 NOK | +0.35% | −25.59% | −12.66% | Oct 28, 2026 |
| HURA | TuHURA Biosciences, Inc. | $2.13 | 0.00% | +184.00% | −26.55% | Nov 13, 2026 |
| ADCT | ADC Therapeutics SA | $1.05 | −5.41% | −70.17% | −67.39% | Nov 10, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $2.27 | +28.98% | −8.84% | −20.91% | Nov 5, 2026 |
| 0RU5.L | Oncoinvent ASA | 85.40 NOK | 0.00% | +96.77% | +7339.02% | Aug 27, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.56 | +30.66% | −48.65% | −29.30% | Nov 12, 2026 |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +8.30% | −12.69% | −19.28% | Nov 16, 2026 |
| HBP.TO | Helix BioPharma Corp. | 1.94 CAD | +33.79% | −19.17% | +46.97% | Oct 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| VRCA | Verrica Pharmaceuticals Inc. | $4.91 | −9.07% | −40.84% | −13.25% | Nov 13, 2026 |
| 0J4V.L | Heron Therapeutics, Inc. | $0.31 | −3.55% | −76.14% | −78.12% | Nov 3, 2026 |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% | Nov 16, 2026 |
| CRDF | Cardiff Oncology, Inc. | $0.98 | +20.01% | −63.00% | −54.65% | Nov 12, 2026 |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% | Nov 5, 2026 |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% | Nov 16, 2026 |
| HRTX | Heron Therapeutics, Inc. | $0.31 | −36.29% | −75.22% | −77.04% | Nov 3, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | 3.19 EUR | −1.30% | −39.91% | −48.50% | Sep 28, 2026 |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% | Nov 25, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% | Oct 30, 2026 |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% | Nov 3, 2026 |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% | Nov 9, 2026 |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +32.39% | −53.00% | −56.48% | Nov 12, 2026 |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −4.55% | −30.00% | −57.43% | Oct 29, 2026 |
| BYSI | BeyondSpring Inc. | $0.69 | −41.77% | −57.14% | −62.09% | Nov 12, 2026 |
| LTRN | Lantern Pharma Inc. | $2.18 | −16.15% | −29.90% | −46.17% | Nov 11, 2026 |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +1.60% | −26.80% | −47.30% | Nov 12, 2026 |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% | Nov 11, 2026 |
| TPST | Tempest Therapeutics, Inc. | $1.08 | +24.00% | −63.39% | −89.96% | Nov 5, 2026 |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +50.00% | −11.22% | −30.40% | Nov 5, 2026 |
| PDSB | PDS Biotechnology Corporation | $0.22 | −67.70% | −73.21% | −82.56% | Nov 12, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% | Sep 28, 2026 |
| 0GP7.L | Medivir AB (publ) | 2.03 SEK | +6.77% | +345.66% | +1.60% | Nov 5, 2026 |
| BCAB | BioAtla, Inc. | $3.12 | −11.61% | −88.31% | −86.04% | Nov 12, 2026 |
| CRIS | Curis, Inc. | $1.54 | −68.12% | +57.14% | −5.52% | Nov 5, 2026 |
| 0HS8.L | Lisata Therapeutics, Inc. | $1.84 | +5.14% | −2.13% | −26.55% | Nov 5, 2026 |
| 0VQ.DE | PureTech Health plc | 1.35 EUR | 0.00% | −12.90% | +1.50% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.